Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants

British Journal of Ophthalmology

Volumn 87, Issue 8, 2003, Pages 1032-1037

  Ciulla, Thomas A ^a   Criswell, M H ^a   Danis, R P ^a   Fronheiser, M ^b   Yuan, P ^b   Cox, T A ^c   Csaky, K G ^c   Robinson, M R ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYVINYL ALCOHOL; TRIAMCINOLONE ACETONIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHOROID CAPILLARY LAYER; CHOROID NEOVASCULAR MEMBRANE; CHOROID VASCULARIZATION; CONTROLLED STUDY; CONVALESCENCE; DRY WEIGHT; FIBROVASCULAR PROLIFERATION; HISTOPATHOLOGY; IMPLANT; KRYPTON LASER; MALE; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL SIGNIFICANCE; STEROID THERAPY; SUSTAINED RELEASE PREPARATION; THICKNESS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG IMPLANTS; GLUCOCORTICOIDS; LASER COAGULATION; MALE; RATS; RATS, INBRED BN; TRIAMCINOLONE ACETONIDE;

EID: 0043207726     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.8.1032     Document Type: Article

References (31)

1. Penfold P, Gyory J, Hunyor A, et al. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 1995;23:293-8.
2. Challa JK, Gillies MC, Penford PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 1998;26:277-81.
3. Danis RP, Ciulla TA, Pratt LM, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-50.
4. Tobe T, Takahashi K, Ohkuma HU, et al. Experimental choroidal neovascularization in the rat. Nippon Ganka Gakkai Zashi 1994;98:837-45.
5. Dobi E, Puliafito C, Destro M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol 1989;107:264-9.
6. Shen W, Yu M, Barry C, et al. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularization in the rat. Br J Ophthalmol 1998;82:1063-71.
7. Ogata N, Yi X, Yamanoto C, et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (Suppl) 1996;37:124.
8. Ogata N, Matsushima M, Takada Y, et al. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr Eye Res 1996;15:1008-18.
9. Ogata N, Yamamoto C, Miyashiro M, et al. Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization. Curr Eye Res 1997;16:9-18.
10. Yi X, Ogata N, Komada M, et al. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 1997;235:313-9.
11. Wada M, Ogata N, Otsuji TU, et al. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr Eye Res 1999;18:203-13.
12. Tobe T, Takahashi K, Ohkuma HU, et al. A long-term course of experimentally produced choroidal neovascularization in the rat. Nippon Ganka Gakkai Zasshi 1995;99:784-91.
13. Zhang N, Samadani E, Frank R. Mitogenesis and retinal pigment epithelial cell antigen expression in the rat after krypton laser photocoagulation. Invest Ophthalmol Vis Sci 1993;34:2412-24.
14. Frank R. Growth factor in age-related macular degeneration:pathogenic and therapeutic implications. Ophthalmic Res 1997;29:341-53.
15. Ciulla TA, Criswell MH, Danis RP, et al. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001;119:399-404.
16. Welling P. Pharmacokinetics:processes and mathematics (American Chemical Society Monograph 185). Washington, DC: American Chemical Society, 1986:145-9.
17. Baker R. Controlled release of biologically active agents. New York: John Wiley, 1987.
18. Ishibashi T, Miki K, Sorgente N, et al. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985;103:708-11.
19. Edelman JL, Castro MR. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 2000;71:523-33.
20. Kvanta A. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res 1995;14:1015-20.
21. Amin R, Puklin J, Frank R. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 1994;35:3178-88.
22. Gilet-Bazeli E, Mashhour B, Pluoet J. Clinicopathologic features of subfoveal membranes in age-related macular degeneration:an immunohistochemical study. Invest Ophthalmol Vis Sci (Suppl) 1996;37:405.
23. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37:855-68.
24. Kliffen M, Sharma H, Mooy C, et al. Increased expression of angiogenic growth factors in age related maculopathy. Invest Ophthalmol Vis Sci (Suppl) 1996;37:203.
25. Reddy VM, Zamora RL, Kaplan HJ. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1995;120:291-301.
26. Folkman J, Ingber D. Angiostatic steroids. Ann Surg 1987;206:374-82.
27. Danis R, Bingaman D, Yang Y, et al. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996;103:2099-104.
28. Penn JS, Rajaratnam VS, Collier RJ, et al. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001;42:283-90.
29. Schlaegel TF. Ocular histoplasmosis. New York: Grune & Stratton., 1977.
30. Martidis A, Miller DG, Ciulla TA, et al. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther 1999;15:425-8.
31. Hughes A. A schematic eye for the rat. Vis Res 1979;19:569-88.